Private Management Group Inc. raised its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 5.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 350,515 shares of the company's stock after purchasing an additional 18,882 shares during the period. Private Management Group Inc. owned 0.28% of Henry Schein worth $24,256,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. ING Groep NV bought a new position in Henry Schein during the third quarter valued at approximately $63,226,000. Holocene Advisors LP acquired a new position in shares of Henry Schein during the 3rd quarter worth $58,319,000. Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of Henry Schein during the 3rd quarter valued at $43,740,000. Southpoint Capital Advisors LP lifted its stake in shares of Henry Schein by 30.0% in the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company's stock valued at $189,540,000 after purchasing an additional 600,000 shares during the last quarter. Finally, Bank of Montreal Can boosted its holdings in Henry Schein by 365.6% in the third quarter. Bank of Montreal Can now owns 711,487 shares of the company's stock worth $52,095,000 after purchasing an additional 558,689 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on the company. Jefferies Financial Group boosted their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. Mizuho initiated coverage on Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 target price for the company. StockNews.com upgraded Henry Schein from a "sell" rating to a "hold" rating in a report on Thursday, November 7th. Barrington Research boosted their price objective on shares of Henry Schein from $82.00 to $90.00 and gave the stock an "outperform" rating in a research note on Thursday, January 30th. Finally, Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and raised their target price for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Seven analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Henry Schein presently has a consensus rating of "Moderate Buy" and a consensus price target of $80.10.
Read Our Latest Stock Report on HSIC
Insider Activity
In other news, COO Michael S. Ettinger sold 12,240 shares of the firm's stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares of the company's stock, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 1.14% of the company's stock.
Henry Schein Price Performance
Shares of Henry Schein stock traded down $0.85 during trading on Friday, hitting $79.00. 1,141,263 shares of the company's stock traded hands, compared to its average volume of 1,474,978. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company has a market cap of $9.85 billion, a PE ratio of 32.51, a PEG ratio of 2.21 and a beta of 0.91. The firm's fifty day moving average price is $73.70 and its 200 day moving average price is $71.78.
About Henry Schein
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading
Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
